MktsMarkets

Immix Biopharma, Inc.
NASDAQ: IMMXKey statistics
IMMX News
Stories mentioning IMMX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 5,980 | 5,728 | 4,584 | 3,972 | 1,975 | 1,374 | 4,446 | 2,224 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 10,804 | 10,892 | 7,663 | 6,718 | 4,683 | 4,988 | 7,395 | 4,702 |
| Operating Income (Loss) | (10,804) | (10,892) | (7,663) | (6,718) | (4,683) | (4,988) | (7,395) | (4,702) |
| Interest Income | 717.00 | 217.00 | 85.00 | 104.00 | 150.00 | 185.00 | 257.00 | 307.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (10,087) | (10,676) | (7,578) | (6,614) | (4,533) | (4,801) | (7,138) | (4,396) |
| Tax Provision | 11.00 | 8.00 | 9.00 | 10.00 | 11.00 | 11.00 | 10.00 | |
| Net Income (Loss) | (10,087) | (10,687) | (7,586) | (6,623) | (4,543) | (4,812) | (7,149) | (4,393) |
| Earnings Per Share (Basic) | (0.18) | (0.32) | (0.24) | (0.22) | (0.15) | (0.17) | (0.24) | (0.15) |
| Earnings Per Share (Diluted) | (0.18) | (0.32) | (0.24) | (0.22) | (0.15) | (0.17) | (0.24) | (0.15) |
| Weighted Average Shares Outstanding (Basic) | 55,369 | 32,966 | 31,927 | 29,984 | 29,701 | 28,286 | 29,424 | 28,785 |
| Weighted Average Shares Outstanding (Diluted) | 55,369 | 32,966 | 31,927 | 29,984 | 29,701 | 28,286 | 29,424 | 28,785 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IMMX
Immix Biopharma, Inc. (NASDAQ: IMMX) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMMX. It last traded at $8.15 (Oct 23, 2026, 4:00 PM ET), down 2.4% on the day. That gives Immix Biopharma a market capitalisation of $675.7M.
Over the past 52 weeks IMMX has traded between $2.85 and $15.10.
For the quarter ended Mar 31, 2026 it reported a net loss of $10.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$10.1M |
| Dec 31, 2025 | — | -$10.7M |
| Sep 30, 2025 | — | -$7.6M |
| Jun 30, 2025 | — | -$6.6M |
From Immix Biopharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…